Catastrophic pharmaceutical expenditure in patients with type 2 diabetes in Iran.

Leila ZareiNajmeh MoradiFarzad PeiravianNazafarin Hatami-MazinaniMotahareh Mahi-BirjandJalal ArablooZaheer-Ud-Din Babar

Published in: International journal for equity in health (2022)

Assessing medication treatment affordability instead of a single medicine assessment is needed. Assessment could be done by utilizing a macro-level data approach and applying adjusted pharmaceutical sector threshold values. Considering the variation between treatment schedules that put patients at risk of catastrophic pharmaceutical expenditures, targeted pharmaceutical policies and reimbursement decisions are recommended to promote Universal Health Coverage (UHC) and to protect vulnerable populations from hardship.

Keyphrases

public health
healthcare
mental health
emergency department
electronic health record
risk assessment
machine learning
deep learning
replacement therapy
big data
human health
adverse drug